Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Influencers are selling a delusional fantasy of being postpartum. Why is it so easy to believe? - 2Hamas set to elect new terror leader with Hayya, Mashaal in pole position
- 3Cuba says 33 have died of mosquito-borne illnesses as epidemic rages
- 4Images of Bangladeshi motorcyclists sleeping at petrol pumps are AI-generated
- 5Guaranteeing Quality Medical care with Federal medical care Benefit Plans.
- Artemis II live updates: NASA's moon mission breaks Apollo record for farthest distance humans have traveled from Earth
- Taylor Momsen explains why she quit 'Gossip Girl': 'I really didn't want to be there'
- Bondi Beach survivor criticizes police for inaction during terror attack
- Why home maintenance deserves a spot in the annual health and budget plans
- Foreign military officials can become Israel's ambassadors, senior IDF commander tells 'Post'
- Osteoporosis, the silent disease, can shorten your life − here’s how to prevent fractures and keep bones healthy
- Beyond oil: The crucial exports blocked by Hormuz closure
- Fossil analysis changes what paleontologists know about how long T. rex took to grow full size
- Major railway disruptions persist as Germany braces for more snow
